In glioblastoma, this pathway downstream of EGFR is often hyperactivated not only by overexpression or activating EGFR mutations but also by Phosphatase and tensin homolog (PTEN) deletion or downregulation, which antagonizes PI3K activity [3]. The gene discussed is EGFR; the disease is glioblastoma.